EW
Edwards Lifesciences Continues to Thrive in 2024 with Strong Financial Performance
The latest conference call transcript from Edwards Lifesciences Corporation has revealed a remarkable fourth quarter performance for the company. Despite TAVR growth falling short of expectations, Edwards' overall sales grew by 9% to $5.4 billion, surpassing the original guidance provided in December last year. During the Q&